WHO-GMP Certified Commercial Pack · Product Code: AKP-002
Ofloxacin 200mg & Ornidazole 500mg Tablets
Formulation Overview: Dual-action antimicrobial fixed-dose combination pairing fluoroquinolone bactericidal coverage with nitroimidazole anaerobic and antiprotozoal activity for mixed gastrointestinal and gynecological infections. Formulated with Ofloxacin IP + Ornidazole IP (200 mg + 500 mg) in Film-Coated Tablets dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 10 Alu-Alu Blister Pack with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-002 |
|---|---|
| Therapeutic Sector | Anti-Infectives & Antibiotics |
| Dosage Form | Film-Coated Tablets |
| Active Ingredient | Ofloxacin IP + Ornidazole IP |
| Strength / Purity | 200 mg + 500 mg |
| Clinical Indication | Mixed aerobic and anaerobic GI infections, infectious diarrhea, dysentery, and pelvic inflammatory disease |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 10 x 10 Alu-Alu Blister Pack |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C, protect from moisture & direct sunlight |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |